Skip to main content

Table 1 The treatment protocols based on the stage of disease

From: Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary

Treatment Number of patients
Stage I. Stage II. Stage III. Stage IV. All
ABVD/EBVD + RT 3 52 9 8 72 (51.5%)
ABVD/EBVD – RT 0 5 9 9 23 (16.5%)
COPP/ABVD + RT 1 3 12 0 16 (11%)
COPP/ABVD – RT 0 0 5 2 7 (5%)
CVPP + RT 1 6 4 1 12 (9%)
CVPP – RT 1 0 2 0 3 (2%)
Other 1 2 4 0 7 (5%)
  1. A(E)BVD: adriamycin (epirubicin), bleomycin, vinblastine and dacarbazine; CV(O)PP: cyclophosphamide, vinblastine [vincristine], procarbazine and prednisolone; COPP/ABV: cyclophosphamide, vincristine, procarbazine, prednisolone/adriamycin, bleomycin and vinblastine; Other protocols include MOPP: mustargen, vincristine, procarbazin, prednisolone, OEPA: vincristine, etoposide, prednisone, and doxorubicin